Work

AMPLIFY-7P: Phase 1 and randomized phase 2 study of amphiphile immunotherapy ELI-002 7P as adjuvant treatment for subjects with G12D, G12R, G12V, G12C, G12A, G12S and G13D Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.3_suppl.tps720

Authors: Zev A. Wainberg, Vincent Chung, Craig E. Devoe, Thomas J. George, Esther Welkowsky, Thian Kheoh, Christopher M. Haqq, Shubham Pant, Eileen Mary O'Reilly

Institutions: University of California, Los Angeles, City Of Hope National Medical Center, City of Hope, Northwell Health, UF Health Cancer Center, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4391091267

Cites:

Cited by: 7

Related to: 10